source
- Vertex to acquire Crinetics in $10 billion deal, adding rare-disease drug Palsonify to its portfolioVertex Pharmaceuticals announced a $10 billion transaction to purchase Crinetics Pharmaceuticals. The deal will bring Crinetics' recently launched drug Palsonify into Vertex's portfolio. Palsonify…
- CMS launches ACCESS program to reward Medicare digital health solutions that improve outcomesThe Centers for Medicare & Medicaid Services introduced the ACCESS program, a new initiative that invites digital health companies to participate in Medicare. The program ties Medicare payments to…